TheraRadar
← Back
Data updated: Mar 29, 2026

CURIUM

OncologyGastroenterologyNeurology
Big Pharma

CURIUM is a major pharmaceutical company focused on Oncology, Gastroenterology, Neurology. Key products include DETECTNET.

1971
Since
18
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

DETECTNET
copper cu-64 dotatate
SSTR2 1 indications · 2020

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

THALLOUS CHLORIDE TL 201 2025-12-10
Labeling
TECHNESCAN PYP KIT 2025-11-24
Labeling
TECHNESCAN HDP 2025-11-24
Labeling
SODIUM IODIDE I 131 2025-06-12
TECHNESCAN PYP KIT 2025-05-22
Labeling
TECHNESCAN HDP 2025-05-22
Labeling
TECHNETIUM TC-99M PENTETATE KIT 2025-03-26
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 59%
2 drugs Phase 3: 3 Phase 2: 1
Gastroenterology 14%
1 drugs
Neurology 14%
1 drugs
Metabolic 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Takeda big-pharma
Oncology, Gastroenterology, Neurology, Metabolic
Amgen biotech
Oncology, Metabolic, Gastroenterology, Neurology
EMD SERONO INC biotech
Oncology, Neurology, Metabolic, Gastroenterology
Eli Lilly big-pharma
Metabolic, Oncology, Neurology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology